Strikingly, SLC12A5 was mainly expressed in tumour cells and most specifically in NPC‐like tumour cells which characterized stem and progenitor cell signatures and highly expressed GABAA receptor and synaptic genes (Figure 7E, Figure S3D–F). The gene discussed is SLC12A5; the disease is neoplasm.